Taking a Closer Look: Clinical and Histopathological Characteristics of Culture-Positive versus Culture-Negative Pulmonary Mucormycosis.

fungal culture hematologic malignancy histopathology mucorales pulmonary mucormycosis transplantation

Journal

Journal of fungi (Basel, Switzerland)
ISSN: 2309-608X
Titre abrégé: J Fungi (Basel)
Pays: Switzerland
ID NLM: 101671827

Informations de publication

Date de publication:
08 Apr 2022
Historique:
received: 09 03 2022
revised: 01 04 2022
accepted: 03 04 2022
entrez: 21 4 2022
pubmed: 22 4 2022
medline: 22 4 2022
Statut: epublish

Résumé

The cultural recovery of Mucorales from hyphae-laden tissue is poor, and the clinical implications of culture positivity are scarcely studied. Therefore, we compared clinical and histopathological characteristics of culture-positive and culture-negative histology-proven pulmonary mucormycosis cases among cancer patients. Histology specimens were blindly reviewed by a thoracic pathologist and graded on four histopathologic features: hyphal quantity, tissue necrosis, tissue invasion, and vascular invasion. Twenty cases with a corresponding fungal culture were identified; five were culture-positive, and fifteen were culture-negative. Although no statistically significant differences were found, culture-positive patients were more likely to exhibit a high burden of necrosis and have a high burden of hyphae but tended to have less vascular invasion than culture-negative patients. In terms of clinical characteristics, culture-positive patients were more likely to have acute myeloid leukemia (60% vs. 27%,

Identifiants

pubmed: 35448611
pii: jof8040380
doi: 10.3390/jof8040380
pmc: PMC9030790
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : NIAID NIH HHS
ID : T32 AI055413
Pays : United States
Organisme : Robert C. Hickey chair endowment
ID : N/a

Références

Am J Clin Pathol. 2003 Jun;119(6):854-8
pubmed: 12817433
J Clin Microbiol. 2005 Jan;43(1):382-6
pubmed: 15634998
J Fungi (Basel). 2021 Mar 17;7(3):
pubmed: 33802827
Am J Clin Pathol. 2013 Jan;139(1):55-61
pubmed: 23270899
J Clin Microbiol. 2021 Jun 18;59(7):e0178420
pubmed: 33504591
Nat Microbiol. 2021 Mar;6(3):313-326
pubmed: 33462434
Am J Clin Pathol. 2007 Feb;127(2):208-12
pubmed: 17210526
PLoS One. 2015 Nov 10;10(11):e0139851
pubmed: 26556047
Clin Infect Dis. 2000 Jun;30(6):851-6
pubmed: 10852735
Clin Infect Dis. 2022 Jan 05;:
pubmed: 34986227

Auteurs

Amy Spallone (A)

Department of Infectious Diseases, Infection Control and Employee Health, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Cesar A Moran (CA)

Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Sebastian Wurster (S)

Department of Infectious Diseases, Infection Control and Employee Health, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Dierdre B Axell-House (DB)

Division of Infectious Diseases, Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX 77030, USA.

Dimitrios P Kontoyiannis (DP)

Department of Infectious Diseases, Infection Control and Employee Health, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Classifications MeSH